Stock listing

NEO Stock Price, News, Filings & Events — Neogenomics, Inc.

Selected listing: NEO · BMV · MXN · MX

This page tracks Neogenomics, Inc.'s NEO:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NEO:BMV. NEO:BMV is the stock-level entry point for investors researching Neogenomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. The company has a market capitalization of approximately $1.81 billion. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.

NEO:BMVMXNMXUpdated August 28, 2026
Neogenomics, Inc. logo
Ticker
NEO:BMV
Asset type
Stock
Market cap
$2.32B
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
BMV
Currency
MXN

Neogenomics, Inc. NEO:BMV stock context

This page tracks Neogenomics, Inc.'s NEO:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NEO:BMV. NEO:BMV is the stock-level entry point for investors researching Neogenomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. The company has a market capitalization of approximately $1.81 billion. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.

Latest news from Neogenomics, Inc.

All Neogenomics, Inc. news →

Neogenomics, Inc. earnings calls

Research Neogenomics, Inc.

Alternate listings